Aging & Elder Health Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Aging & Elder Health Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Innocoll, Inc.
Specialty pharmaceutical company granted patents for wound-healing products
April 10th, 2005
Innocoll, Inc., announced that its wholly owned subsidiary, Syntacoll AG, has been granted U.S. Patent No. 6,855,860 entitled "Composite Dressings for Treatment of Wounds" by the U.S. Patent and Trademark Office, and Patent No. 1263485 entitled "Multilayer Collagen Matrix for Tissue Reconstruction" by the European Patent Office. The U.S. patent covers a product comprised of a novel collagen-based composite material designed for the treatment of deep wounds, or wounds that penetrate the middle and deepest layers of skin. These deep wounds occur in second- or third-degree burns and in a variety of acute and/or chronic skin disorders, such as leg ulcers...
Source: Aging & Elder Health Week (2005-04-10)
|
